Human cytomegalovirus immunity and immune evasion
- PMID: 21056604
- DOI: 10.1016/j.virusres.2010.10.031
Human cytomegalovirus immunity and immune evasion
Abstract
Human cytomegalovirus (HCMV) infection induces both innate immune responses including Natural Killer cells as well as adaptive humoral and cell mediated (CD4+ helper, CD8+ cytotoxic and γδ T cell) responses which lead to the resolution of acute primary infection. Despite such a robust primary immune response, HCMV is still able to establish latency. Long term memory T cell responses are maintained at high frequency and are thought to prevent clinical disease following periodic reactivation of the virus. As such, a balance is established between the immune response and viral reactivation. Loss of this balance in the immunocompromised host can lead to unchecked viral replication following reactivation of latent virus, with consequent disease and mortality. HCMV encodes multiple immune evasion mechanisms that target both the innate and acquired immune system. This article describes the current understanding of Natural killer cell, antibody and T cell mediated immune responses and the mechanisms that the virus utilizes to subvert these responses.
Copyright © 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.J Virol. 2017 Oct 27;91(22):e00678-17. doi: 10.1128/JVI.00678-17. Print 2017 Nov 15. J Virol. 2017. PMID: 28878085 Free PMC article.
-
Generation, maintenance and tissue distribution of T cell responses to human cytomegalovirus in lytic and latent infection.Med Microbiol Immunol. 2019 Aug;208(3-4):375-389. doi: 10.1007/s00430-019-00598-6. Epub 2019 Mar 20. Med Microbiol Immunol. 2019. PMID: 30895366 Free PMC article. Review.
-
Battle between Host Immune Cellular Responses and HCMV Immune Evasion.Int J Mol Sci. 2019 Jul 24;20(15):3626. doi: 10.3390/ijms20153626. Int J Mol Sci. 2019. PMID: 31344940 Free PMC article. Review.
-
Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4+ and CD8+ T Cells.Front Immunol. 2018 May 25;9:1129. doi: 10.3389/fimmu.2018.01129. eCollection 2018. Front Immunol. 2018. PMID: 29887865 Free PMC article.
-
In vivo impact of cytomegalovirus evasion of CD8 T-cell immunity: facts and thoughts based on murine models.Virus Res. 2011 May;157(2):161-74. doi: 10.1016/j.virusres.2010.09.022. Epub 2010 Oct 8. Virus Res. 2011. PMID: 20933556 Review.
Cited by
-
Human cytomegalovirus microRNAs: strategies for immune evasion and viral latency.Arch Virol. 2024 Jul 6;169(8):157. doi: 10.1007/s00705-024-06080-w. Arch Virol. 2024. PMID: 38969819 Review.
-
Evaluation of Bispecific T-Cell Engagers Targeting Murine Cytomegalovirus.Viruses. 2024 May 29;16(6):869. doi: 10.3390/v16060869. Viruses. 2024. PMID: 38932161 Free PMC article.
-
Cellular Transformation by Human Cytomegalovirus.Cancers (Basel). 2024 May 22;16(11):1970. doi: 10.3390/cancers16111970. Cancers (Basel). 2024. PMID: 38893091 Free PMC article.
-
Human Cytomegalovirus Oncoprotection across Diverse Populations, Tumor Histologies, and Age Groups: The Relevance for Prospective Vaccinal Therapy.Int J Mol Sci. 2024 Mar 27;25(7):3741. doi: 10.3390/ijms25073741. Int J Mol Sci. 2024. PMID: 38612552 Free PMC article.
-
Human cytomegalovirus seropositivity and its influence on oral rotavirus vaccine immunogenicity: a specific concern for HIV-exposed-uninfected infants.Clin Exp Immunol. 2024 Jun 20;217(1):99-108. doi: 10.1093/cei/uxae029. Clin Exp Immunol. 2024. PMID: 38546123 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials